Strategic challenges in neurotherapeutic pharmaceutical development

Area of Science:

• Neuroscience and Drug Development
• Biotechnology and Information Science
• Healthcare Economics

Background:

• Therapeutic development faces economic, scientific, and medical challenges.
• Neurotherapeutics development is particularly complex due to the central nervous system (CNS) complexity, unclear disease origins, inadequate animal models, and difficulties in defining patient populations and measuring treatment outcomes.
• Existing paradigms for drug development require enhancement to overcome these hurdles.

Purpose of the Study:

• To review the economic and scientific challenges in general therapeutics development, with a specific focus on neurotherapeutics.
• To propose a novel industrial strategy, the Biodesign strategy, to improve future therapeutics development.
• To explore how this strategy can enhance drug discovery and address economic challenges in healthcare.

Main Methods:

• Review of economic challenges in therapeutics and neurotherapeutics development.
• Discussion of scientific challenges pertinent to neurotherapeutics.
• Proposal and elaboration of the Biodesign strategy, incorporating disease modeling, information science, biological technologies, and improved animal model utilization.
• Analysis of the potential impact on company business models and healthcare economics.

Main Results:

• The Biodesign strategy integrates disease modeling for target selection, information science for chemistry enhancement, biological technologies for mechanistic probes, and improved animal/human studies.
• This synergistic approach can significantly alter the business models of neurotherapeutics companies.
• The strategy has the potential to substantially improve the development of new therapies.

Conclusions:

• The proposed Biodesign strategy offers a paradigm shift for therapeutics development, particularly in neurotherapeutics.
• It addresses key scientific complexities and economic challenges.
• Successful implementation can lead to enhanced therapy development and improved healthcare economic outcomes.